drugset / Trial / NCT05851261
Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
The primary objectives of this study are to evaluate the safety and tolerance of single and multiple oral administration of PA3670 tablets in Chinese adult healthy subjects and the effect of food on pharmacokinetics of PA3670 tablets in Chinese adult healthy subjects.
Timeline
- Start
- 2023-04-13
- Primary completion
- 2023-10-24
- Completion
- 2023-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PA3670 | Unknown | 5 mg | Oral |
| Subject | PA3670 | Unknown | 10 mg | Oral |
| Subject | PA3670 | Unknown | 15 mg | Oral |
| Subject | PA3670 | Unknown | 30 mg | Oral |